We are live on ! Find out more
CATX icon

Perspective Therapeutics
CATX

38 hedge funds and large institutions have $3.94M invested in Perspective Therapeutics in 2020 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% more capital invested

Capital invested by funds: $3.84M → $3.94M (+$105K)

0% more funds holding

Funds holding: 38 → 38 (0)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

0.02% less ownership

Funds ownership: 1.07% → 1.05% (-0.02%)

29% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 7

Holders
38
Holders Change
–
Holders Change %
0%
% of All Funds
0.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
5
Reduced
7
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$253K
2
BCM
Bridgeway Capital Management
Texas
+$183K
3
Citadel Advisors
Citadel Advisors
Florida
+$33.6K
4
Cerity Partners
Cerity Partners
New York
+$25.7K
5
OCPWS
One Charles Private Wealth Services
Massachusetts
+$12.9K

Top Sellers

Rank Fund Capital Flow
1
EI
EAM Investors
California
-$496K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$50.8K
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$50.4K
4
UBS Group
UBS Group
Switzerland
-$22.9K
5
Victory Capital Management
Victory Capital Management
Texas
-$7.76K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.33M – – –
BlackRock
2
BlackRock
New York
$641K -$1.4K -217 -0.2%
Renaissance Technologies
3
Renaissance Technologies
New York
$599K +$253K +39,389 +58%
HPWM
4
Highland Private Wealth Management
Washington
$301K – – –
Geode Capital Management
5
Geode Capital Management
Massachusetts
$179K – – –
EI
6
EAM Investors
California
$172K -$496K -77,095 -71%
BCM
7
Bridgeway Capital Management
Texas
$158K +$183K +28,400 New
Northern Trust
8
Northern Trust
Illinois
$71K +$6.93K +1,077 +9%
CWM
9
Cahaba Wealth Management
Georgia
$69K – – –
California Public Employees Retirement System
10
California Public Employees Retirement System
California
$65K – – –
Citadel Advisors
11
Citadel Advisors
Florida
$42K +$33.6K +5,224 +225%
SIA
12
Starfire Investment Advisers
Michigan
$38K – – –
Acadian Asset Management
13
Acadian Asset Management
Massachusetts
$30K -$50.4K -7,840 -60%
CAG
14
Crestwood Advisors Group
Massachusetts
$30K – – –
CPIG
15
Chicago Partners Investment Group
Illinois
$24K – – –
Cerity Partners
16
Cerity Partners
New York
$22K +$25.7K +4,000 New
Commonwealth Equity Services
17
Commonwealth Equity Services
Massachusetts
$21K +$8.68K +1,350 +53%
IFS
18
Ifrah Financial Services
Arkansas
$17K – – –
AF
19
Advisornet Financial
Minnesota
$13K – – –
Creative Planning
20
Creative Planning
Kansas
$12K – – –
RJFSA
21
Raymond James Financial Services Advisors
Florida
$12K +$1.93K +300 +15%
Royal Bank of Canada
22
Royal Bank of Canada
Ontario, Canada
$11K -$1.14K -177 -8%
OCPWS
23
One Charles Private Wealth Services
Massachusetts
$11K +$12.9K +2,000 New
FIM
24
Frontier Investment Management
Texas
$10K – – –
HWM
25
HighMark Wealth Management
Minnesota
$10K – – –
1
2

CATX Hedge Fund Activity: Q2 2020 in Review

38 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Perspective Therapeutics (CATX) for Q2 2020, worth a combined $3.94M — up 2.7% from $3.84M a quarter earlier.

Fund positioning in CATX was balanced in Q2 2020: 4 funds opened new positions, 4 closed out, 5 added to existing stakes and 7 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $253K. The largest seller was EAM Investors, cutting an estimated $496K.

  • 38 institutional investors held Perspective Therapeutics (CATX) as of Q2 2020, unchanged from Q1 2020.
  • Funds reported $3.94M of Perspective Therapeutics stock for Q2 2020, up 2.7% quarter-over-quarter.
  • 4 funds opened new Perspective Therapeutics positions in Q2 2020 and 4 closed out, a net change of 0 holders.
  • The largest Perspective Therapeutics buyer in Q2 2020 was Renaissance Technologies, an estimated $253K added.
  • The largest Perspective Therapeutics seller in Q2 2020 was EAM Investors, an estimated $496K sold.

Based on aggregated 13F filings for Q2 2020.